Workflow
Commercial nuclear components
icon
Search documents
BWX Technologies(BWXT) - 2025 Q2 - Earnings Call Presentation
2025-08-04 21:00
Financial Performance - Revenue increased by 12%, driven by growth in both Government Operations and Commercial Operations segments; organic growth was up 4%[5,9] - Adjusted EBITDA increased by 16% and Non-GAAP EPS increased by 24%, driven by higher operating earnings and modestly higher other income[5,9] - Free Cash Flow was $126 million[5,9] - Record backlog reached $6.0 billion, up 70% year-over-year[5] Segment Performance - Government Operations revenue increased by 9%, with organic revenue up 6%, leading to an adjusted EBITDA margin of 22.6%[5,14] - Commercial Operations revenue increased by 24%, driven by double-digit medical growth and the Kinectrics acquisition, but organic revenue decreased by 3%[5,14] - Commercial Operations backlog of $1.6 billion, up 22% quarter-over-quarter and 136% year-over-year[5] Guidance - Revenue guidance raised to approximately $3.1 billion[5,17] - Adjusted EBITDA guidance raised to $565 million to $575 million[5,17] - Non-GAAP EPS guidance raised to $3.65 to $3.75[5,17] - Free Cash Flow guidance increased to $275 million to $285 million[5,17]